Mora J - Search Results

1

Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium.

Starcevic Manning M, Hassanein M, Partridge MA, Jawa V, Mora J, Ryman J, Barker B, Braithwaite C, Carleton K, Hay L, Hottenstein C, Kubiak RJ, Devanarayan V. Starcevic Manning M, et al. Among authors: mora j. AAPS J. 2022 Jul 12;24(4):81. doi: 10.1208/s12248-022-00728-8. AAPS J. 2022. PMID: 35821280

2

Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing.

Mora J, Given Chunyk A, Dysinger M, Purushothama S, Ricks C, Osterlund K, Theobald V. Mora J, et al. AAPS J. 2014 Nov;16(6):1175-84. doi: 10.1208/s12248-014-9660-1. Epub 2014 Sep 6. AAPS J. 2014. PMID: 25193269 Free PMC article. Review.

3

Evaluation of acoustic membrane microparticle (AMMP) technology for a sensitive ligand binding assay to support pharmacokinetic determinations of a biotherapeutic.

Chilewski SD, Dickerson WM, Mora JR, Saab A, Alderman EM. Chilewski SD, et al. AAPS J. 2014 Nov;16(6):1366-71. doi: 10.1208/s12248-014-9659-7. Epub 2014 Sep 23. AAPS J. 2014. PMID: 25245223 Free PMC article.

4

Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle Technology.

Dong H, Mora JR, Brockus C, Chilewski SD, Dodge R, Merrifield C, Dickerson WM, DeSilva B. Dong H, et al. AAPS J. 2015 Nov;17(6):1511-6. doi: 10.1208/s12248-015-9799-4. Epub 2015 Jul 3. AAPS J. 2015. PMID: 26139446 Free PMC article.

5

An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab.

Passey C, Mora J, Dodge R, Gibiansky L, Sheng J, Roy A, Bello A, Gupta M. Passey C, et al. Among authors: mora j. AAPS J. 2017 Mar;19(2):557-567. doi: 10.1208/s12248-016-0033-9. Epub 2017 Jan 9. AAPS J. 2017. PMID: 28070715

6

Generic Anti-PEG Antibody Assay on ProterixBio's (Formerly BioScale) ViBE Platform Shows Poor Reproducibility.

Chilewski SD, Shields J, Mora JR, Myler H. Chilewski SD, et al. Among authors: mora jr. AAPS J. 2018 Apr 24;20(3):65. doi: 10.1208/s12248-018-0228-3. AAPS J. 2018. PMID: 29691672

7

Immunogenicity Risk Assessment for PEGylated Therapeutics.

Mora JR, White JT, DeWall SL. Mora JR, et al. AAPS J. 2020 Jan 28;22(2):35. doi: 10.1208/s12248-020-0420-0. AAPS J. 2020. PMID: 31993858 Review.

8

AAPS Perspective on the EURL Recommendation on the use of Non-Animal-Derived Antibodies.

Gorovits B, Hays A, Jani D, Jones C, King C, Lundequist A, Mora J, Partridge M, Pathania D, Ramaswamy SS, Rutwij D, Shen H, Starling G. Gorovits B, et al. Among authors: mora j. AAPS J. 2021 Mar 1;23(2):34. doi: 10.1208/s12248-021-00567-z. AAPS J. 2021. PMID: 33649990

9

Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum.

Dai Y, Dong H, Gleason C, Mora J, Kolaitis G, Balasubramanian N, Surapaneni S, Kozhich A, Jawa V. Dai Y, et al. Among authors: mora j. AAPS J. 2023 Apr 3;25(3):35. doi: 10.1208/s12248-023-00805-6. AAPS J. 2023. PMID: 37012501

10

The AAPS Journal Theme Issue: Compendium of Immunogenicity Risk Assessments: an Industry Guidance Built on Experience and Published Work.

Mora JR, Richards SM. Mora JR, et al. AAPS J. 2023 Apr 20;25(3):43. doi: 10.1208/s12248-023-00796-4. AAPS J. 2023. PMID: 37081214 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,189 results

Search Page

Filters